a month later, a third case was confirmed.
The FDA allowed the drug to return to the
market in July 2006 after they stated benefits
outweighed the risks, no doubt with some
help from Big Pharma.
GW received government approval in 1998 to
develop cannabis-based plant extracts.
Their flagship product Sativex is a highly
defined extract containing an approximately
50-50 mix of CBD and THC that has been
approved by regulators in the UK and more
than 20 other countries for treating pain and
spasticity in Multiple Sclerosis.
Some forms of medical marijuana are proven
to alleviate certain symptoms in patients with
multiple sclerosis (MS), according to
guidelines published in the journal
Neurology.
In a review of 2,608 studies, researchers were
able to assess which therapies had sufficient
evidence to indicate that they may be effective
for patients with MS. Overall, researchers
discovered that certain forms of medical
marijuana, a spray form and a pill form
appeared to have the most evidence indicating
they may be helpful in patients with MS.
According to study author Dr. Pushpa
Narayanaswami: “What we learned are these
specific forms of medical marijuana can ease
patients’ symptoms — specific symptoms of
spasticity, or muscle stiffness … and helped
with frequent urination.”
In a 2011 study, Israeli researchers showed
that CBD helps treat MS-like symptoms by
preventing immune cells from transforming
and attacking the insulating covers of nerve
cells in the spinal cord.
After inducing an MS-like condition in mice
partially paralysing their limbs — the
researchers injected them with CBD.
The mice responded by regaining movement,
first twitching their tails and then beginning to
walk without a limp.
The researchers noted that the mice treated
with CBD had much less inflammation in the
spinal cord than their untreated counterparts.
In another study in Neuroscience, researchers
used
experimental
autoimmune
encephalomyelitis (EAE), an animal model of
MS, and found that cannabinoids reduced
microglia activation, nitrotyrosine formation,
T cell infiltration, oligodendrocyte toxicity,
myelin loss and axonal damage in the mouse
spinal cord white matter and alleviated the
clinical scores when given either before or
after disease onset.
5. ADHD/ADD
The normal course of treatment for a child
diagnosed with ADD/ADHD, is a course of
methylphenidate, better known as Ritalin.
For the child diagnosed with ADD/ADHD,
the side effects of using Ritalin, are many,
including psychosis (abnormal thinking or
hallucinations), difficulty sleeping, stomach
aches, diarrhea, headaches, lack of hunger
(leading to weight loss) and dry mouth.
In some cases, the use of Ritalin has led to
death. Death can be caused due to burst blood
vessels, heart failure and fever.
Violence is a leading cause of amphetamine-
related deaths.
Violent tendencies can develop after even
regular use.
Children are dying at unprecedented rates
from drugs like Ritalin.
An excellent documentary Generation Rx,
details the disturbing and ongoing chemical
abuse of children by conventional medicine.
The prescription of psychiatric drugs to the
masses, specifically children, are altering
their minds, bodies and entire lives.
While some apply preconceptions that
marijuana exacerbates ADHD, almost all
California cannabinologists believe cannabis
and
cannabinoids
have
substantially
improved the lives of ADHD sufferers, and
with less negative side effects than common
stimulant drug ADHD treatments.
We have come to understand more about the
brain and the role of dopamine and the
endocannabinoid system we are starting to
unravel how cannabis, anandamide and